Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Mild cognitive impairment and mild dementia: The role of ginkgo biloba (EGb 761®)

Title: Mild cognitive impairment and mild dementia: The role of ginkgo biloba (EGb 761®)
Authors: Tomino C.; Ilari S.; Solfrizzi V.; Malafoglia V.; Zilio G.; Russo P.; Proietti S.; Marcolongo F.; Scapagnini G.; Muscoli C.; Rossini P. M.
Contributors: Tomino, C.; Ilari, S.; Solfrizzi, V.; Malafoglia, V.; Zilio, G.; Russo, P.; Proietti, S.; Marcolongo, F.; Scapagnini, G.; Muscoli, C.; Rossini, P. M.
Publisher Information: MDPI; MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
Publication Year: 2021
Collection: Sapienza Università di Roma: CINECA IRIS
Subject Terms: alzheimer’s disease; ginkgo biloba (Egb761®); Tebonin; anti-dementia drug; mild cognitive impairment (MCI); mild dementia; randomized controlled trials
Description: Mild cognitive impairment (MCI) and dementia are clinically prevalent in the elderly. There is a high risk of cognitive decline in patients diagnosed with MCI or dementia. This review describes the effectiveness of Ginkgo biloba leaf special extract EGb 761(R) for the treatment of dementia syndromes and EGb 761(R) combination therapy with other medications for symptomatic dementia. This drug has shown convincing results, improving cognitive function, neuropsychiatric symptoms and consequent reduction of caregiver stress and maintenance of autonomy in patients with age-related cognitive decline, MCI and mild to moderate dementia. Currently, there is little evidence to support the combination therapy with anti-dementia drugs and, therefore, more evidence is needed to evaluate the role of EGb 761(R) in mixed therapy.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/33915701; info:eu-repo/semantics/altIdentifier/wos/WOS:000643368700001; volume:14; issue:4; journal:PHARMACEUTICALS; https://hdl.handle.net/11573/1753963
DOI: 10.3390/ph14040305
Availability: https://hdl.handle.net/11573/1753963; https://doi.org/10.3390/ph14040305
Rights: info:eu-repo/semantics/openAccess ; license:Tutti i diritti riservati (All rights reserved) ; license uri:iris.PRI00
Accession Number: edsbas.C55E1EB5
Database: BASE